Quick Answer
Lifevantage Corp reported R&D Expense of $2.95 million for fiscal year 2013.
Lifevantage Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2013 | $2.95M | +116.9% |
| 2012 | $1.36M | +167.0% |
| 2011 | $509.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| March 31, 2014 | $655.0K | -22.8% | +12.2% |
| December 31, 2013 | $584.0K | -21.3% | +90.2% |
| September 30, 2013 | $307.0K | -40.3% | -63.8% |
| March 31, 2013 | $848.0K | +124.3% | +14.3% |
| December 31, 2012 | $742.0K | +137.8% | +44.4% |
| September 30, 2012 | $514.0K | +119.7% | +36.0% |
| March 31, 2012 | $378.0K | +227.2% | +21.2% |
| December 31, 2011 | $312.0K | +247.8% | +33.3% |
- Lifevantage Corp showed an increase of +116.9% in R&D Expense compared to the prior fiscal year.
- Over the 2011–2013 period, Lifevantage Corp’s r&d expense has grown by 479.2% (from $509.0 thousand to $2.95 million).
- The most recent figure is from Lifevantage Corp’s fiscal year 2013 report (Form 10-K), filed with the SEC on September 12, 2013.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: